DrugBank - About the company
DrugBank is a seed company based in Edmonton (Canada), founded in 2006 by Michael Wilson. It operates as a Drug database for life sciences and healthcare and clinical APIs. DrugBank has raised $9M in funding from Brightspark Ventures and BoxOne Ventures. The company has 49 active competitors, including 13 that are funded. Its top competitors include companies like Truveta, Seg Med and nference.
Company Details
The company offers drug databases for clinical and academic research. It also offers a clinical API software that provides decision support and analytics based on the database.
- Website
- drugbank.com
- Email ID
- *****@drugbank.com
- Registered Address
- A 102 Gala Quest, Paranjpe Scheme B Road No. 1, Vileeparle (East), Mumbai, Mumbai, Maharashtra, India, 400057
Key Metrics
Founded Year
2006
Location
Edmonton, Canada
Stage
Seed
Total Funding
$9M in 2 rounds
Latest Funding Round
Investors
Ranked
7th among 49 active competitors
Employee Count
61 as on May 31, 2026
Legal entities associated with DrugBank
DrugBank is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
OMx Personal Health Analytics Inc. CIN: 826702-2 , Canada, Active | Aug 03, 2012 | - | - | - |
FINDABILITY SCIENCES PRIVATE LIMITED CIN: U74999MH2009PTC194842 , India, Active | Aug 11, 2009 | ₹10 - ₹50 Cr (As on Mar 31, 2025) | 93 (As on Jul 01, 2025) |
Sign up to download DrugBank's company profile
DrugBank's funding and investors
DrugBank has raised a total funding of $9M over 2 rounds. Its first funding round was on Oct 05, 2020. Its latest funding round was a Seed round on Apr 11, 2022 for $*****. 6 investors participated in its latest round. DrugBank has 11 institutional investors and 2 angel investors.
Here is the list of recent funding rounds of DrugBank:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 11, 2022 | 6707344 | Seed | 5101096 | 1653966 | 9400206 | 7826746 |
Oct 05, 2020 | 5105450 | Seed | 7065835 | 8762866 |
View details of DrugBank's funding rounds and investors
DrugBank's founders and board of directors
Founder? Claim ProfileThe founders of DrugBank is Michael Wilson.
Here are the details of DrugBank's key team members:
- Michael Wilson: Co-Founder & CPO of DrugBank.
DrugBank's Board of Directors
DrugBank's board has 4 active members. Craig Knox, Theo Risopoulos, Eleonore Jarry-Ferron and Susan Roberts are independent board members.Here is the list of DrugBank's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 12y 8m | |
mtlsb{y | Independent board member | - | Current | 6y 8m |
fzujqdp | Independent board member | - | Current | 4y 6m |
bzvludu | Independent board member | - | Current | 7y 7m |
View details of DrugBank's Founder profiles and Board Members
DrugBank's employee count trend
DrugBank has 61 employees as of May 26. Here is DrugBank's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
DrugBank's Competitors and alternates
Top competitors of DrugBank include Truveta, Seg Med and nference. Here is the list of Top 10 competitors of DrugBank, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Truveta 2020, Seattle (United States), Series C | Provider of healthcare data platform for learning services | $515M | 65/100 | |
2nd | Seg Med 2019, Stanford (United States), Series A | Provider of AI based clinical data management software and services for researchers | $17.7M | 61/100 | |
3rd | nference 2013, Cambridge (United States), Series C | Provider of an AI platform for clinical data analysis and insights | $134M | 58/100 | |
4th | Verana Health 2011, San Francisco (United States), Series E | Online platform for clinical trail data analytics and management software for researchers | $288M | 58/100 | |
5th | Flywheel 2015, Minneapolis (United States), Series D | Cloud based data research platform | $154M | 55/100 | |
6th | Provider of an AI based data analytics solution for reserachers | $14.2M | 54/100 | ||
7th | Drug database for life sciences and healthcare and clinical APIs | $9M | 53/100 | ||
8th | Convergence CT 2001, Honolulu (United States), Series B | Suite of solutions for health informatics | $29.4M | - | 38/100 |
9th | LunaDNA 2017, Solana Beach (United States), Deadpooled | Developer of community-owned health and DNA data platform | $15M | 37/100 | |
10th | Pangaeadata Ai 2017, United Kingdom, Seed | Provider of AI-based medical and healthcare data analysis for providers and researchers | - | 36/100 |
Looking for more details on DrugBank's competitors? Click here to see the top ones
DrugBank's Investments and acquisitions
DrugBank has made no investments or acquisitions yet.
Reports related to DrugBank
Here is the latest report on DrugBank's sector:
News related to DrugBank
Media has covered DrugBank for a total of 2 events in the last 1 year, 1 of them has been about partnerships and 1 about people movement.
•
•
•
•
•
DrugBank Raises $9M in Seed FundingFinSMEs•Apr 11, 2022•DrugBank, Brightspark Ventures, Amplitude, Theodorus and 3 others
Are you a Founder ?
FAQs about DrugBank
Explore our recently published companies
- Greyledge Consulting - Canton based, Unfunded company
- Juno Bio - United Kingdom based, 2013 founded, Unfunded company
- Justice Leadership - United States based, 2010 founded, Unfunded company
- Studio B3 Creative - Unfunded company
- InfrasofTech - Bhubaneswar based, 2025 founded, Unfunded company
- Devon Victoria - 2016 founded, Unfunded company
